Log In
Print
BCIQ
Print
Print this Print this
 

Anti-IL-6R (ALX-0061)

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionNanobody against IL-6 receptor (CD126)
Molecular Target Interleukin-6 (IL-6) receptor (CD126)
Mechanism of ActionInterleukin-6 (IL-6) receptor (CD126) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat moderate to severe active rheumatoid arthritis (RA)
Regulatory Designation

Partner

AbbVie Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today